$EOSS - Since its establishment in 2022, ZHONGKEZHONGLUAN has been committed to the research and development and transformation of cutting-edge biomedical technologies. With more than 3,700 world-leading core technologies, ZHONGKEZHONGLUAN is at the forefront of regenerative medicine and biotechnology.
https://www.otcmarkets.com/stock/EOSS/news/EO...?id=425710